A Pilot Study of Imatinib Mesylate in Steroid Refractory Chronic Graft Versus Host Disease

NCT00760981 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Graft vs Host Disease

Interventions

DRUG: Imatinib

Sponsor

David Miklos

Collaborators

[object Object]